Antimicrobial Susceptibility Testing Market Size, Share, Growth Analysis, By Test type(Phenotypic testing, genotypic testing, and rapid testing), By End user(Hospitals and diagnostic laboratories, research and academic institutes, and pharmaceutical and biotechnology companies), By Product type(Instruments, reagents and kits, and software and services), By Region - Industry Forecast 2025-2032

Geographically, North America dominated the market in the previous years and is expected to lead over the forecast period owing to the developed healthcare infrastructure, strong research and development, and rising cases of infectious diseases. The region holds high-tech healthcare systems with superior diagnostic facilities and laboratories, allowing widespread adoption of antimicrobial susceptibility testing. There is a robust investment in research and development from private and public firms that nurture advancements and innovations in AST methods and technologies. The region also faces a large population with infectious diseases, thus impacting regional growth. The key players profiled in the region include Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Inc., Becton, Dickinson and Company, Abbott Laboratories, Agilent Technologies, Inc., and more.

Asia-Pacific is the fastest-growing region in the global antimicrobial susceptibility testing market due to the increasing prevalence of infectious diseases, rising awareness of (AMR) Antimicrobial Resistance, and enhancing healthcare infrastructure. The region is witnessing the growing incidences of infectious diseases, rising the demand for efficient testing. Recognition and increased awareness of AMR concerns is triggering healthcare providers and governments to emphasize AST as a unit of public health strategies. Also, several nations of Asia-Pacific are focusing on investment in developing diagnostic capabilities and healthcare infrastructure, thus aiding the adoption of AST tools. The market is also fueled by speedy economic growth, resulting in more healthcare spending and investments in R&D.